
1001 - 5000 employees
🏭 Manufacturing
🏥 Healthcare
💼 Consulting
💰 $600M Post-IPO Debt - Repligen on 2023-12
Manufacturing • Healthcare • Consulting
<Repligen Corporation> Repligen Corporation is a life sciences company focused on bioprocessing technology leadership, providing scalable hardware, consumables and software for development and manufacture of biologic drugs and advanced therapies. Its portfolio includes upstream intensification systems (XCell ATF, KrosFlo TFDF), tangential flow filtration devices (KrosFlo, TangenX), chromatography systems and resins (KRM, OPUS, affinity and ion exchange resins), single-use fluid management and mixing solutions (ProConnex, MixOne, FlexBiosys products), dialysis devices, and real-time process analytics and control software (PATsmart, SoloVPE, FlowVPX). Repligen supports production of antibodies, proteins, viral vectors, mRNA, pDNA and other emerging modalities, and offers services, configurators and cGMP-ready solutions for biopharmaceutical manufacturers.
🕒 5 days ago
Inside Sales Account Manager driving revenue for Repligen’s bioprocessing products. Generating leads, closing sales, managing customer relationships, and collaborating with field sales and marketing teams.
🇬🇧 United Kingdom – Remote
💰 $600M Post-IPO Debt - Repligen on 2023-12
⏰ Full Time
🟢 Junior
🟡 Mid-level
⬇️ Inside Sales
🕒 July 14
Inside Sales Account Manager generating and qualifying leads for Repligen. Responsible for closing sales and maintaining customer relationships.
🌐 Netherlands, Austria, +3 more countries – Remote
💰 $600M Post-IPO Debt - Repligen on 2023-12
⏰ Full Time
🟢 Junior
🟡 Mid-level
⬇️ Inside Sales